📢 Inviting all interventional cardiologists to complete a survey on the utilization of coronary physiology. Help our understanding of current practices, including usage frequency, preferred modalities, and optimal timing. 🔗Complete the survey now:

RT @JACCJournals: In the FAME 3 trial, at 3 years, women had similar outcomes with #FFR-guided #PCI compared with #CABG, whereas men had im….

RT @CircIntv: How does a bifurcation lesion influence your revascularization strategy? Impact of bifurcation lesions on outcomes after FFR-….

RT @CircIntv: How does the presence of a CTO effect outcomes in FFR guided therapy for 3-vessel CAD? A comparison of PCI versus CABG. A FAM….

RT @CircAHA: #SimPub #CircTCT24 #Editorial What can coronary physiological testing teach us about which patients may derive anginal benefit….

RT @rushiparikh11: Interventional Cards Twitter—need your help to assess current global trends in invasive coronary physiology use. Please….

RT @CircIntv: In an era of increasing aortic valve-in-valve procedures what have we learned? A call for papers for our special themed issu….

RT @SeanM_Wu: #TeamScience meeting discussion at CV Medicine Division @StanfordDeptMed 2 facilitate greater collaborations among faculty wi….

Most of us have seen patients with low EF and CAD who have benefitted from PCI. The key is how to best identify these patients. REVIVED gives us pause in treating all patients. We need to get better at identifying those who are most likely to benefit. #CardsJC.

Although viability was demonstrated, one wonders if all lesions treated were responsible for ischemia. Ischemia-producing lesions are the ones most likely to benefit from PCI. #CardsJC.

Also more angina in STITCH. The low rate of significant angina in REVIVED is important to note. Those patients with significant angina are the ones who are most likely to benefit from PCI with respect to quality of life. #CardsJC.

It is always hard to enroll all comers in studies like this where the treatment strategies are so different. Slow enrolment with few patients per month from each center suggests that this was a select population. Need to take this into account when analyzing the results. #CardsJC.

RT @CircIntv: The Impact of Serial Coronary Stenoses on Various Coronary Physiology Indices. @wfearonmd #AHAJourna….

Congrats @JungMinAhn5 on publishing these data in @CircIntv evaluating cross-talk from serial lesions with NHPRs and FFR.

RT @CircIntv: Post-PCI FFR in FAME 3. What do the numbers tell us? A LBCT @CRF #TCT2022 and published simultaneously in Circulation: Cardio….

RT @CircAHA: #OriginalResearch SimPub #ACC22: New data from #FAME3 RCT: In 3-vessel CAD, FFR-guided #PCI and #CABG yielded similar #QoL aft….

RT @Ortega_Paz: #EAPCI Quality of Life After FFR-Guided PCI Compared w/ CABG @PCRonline @escardio @ESC_Journals….

Thanks for the invitation!!.#CardsJC.

A key question that needs to be answered about higher event rates in FFR-deferred ACS patients c/w FFR-deferred stable pts is whether the events are due to the FFR-deferred lesion or the ACS substrate. #CardsJC.

Great ? about PCI outcome in diabetics and low SYNTAX score. We will have to look. There may not be that many!.#CardsJC.